HomeCompareMDCLF vs FCPT

MDCLF vs FCPT: Dividend Comparison 2026

MDCLF yields 5.82% · FCPT yields 6.05%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 FCPT wins by $19.7K in total portfolio value
10 years
MDCLF
MDCLF
● Live price
5.82%
Share price
$34.39
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$29.3K
Annual income
$842.73
Full MDCLF calculator →
FCPT
FCPT
● Live price
6.05%
Share price
$23.65
Annual div
$1.43
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.1K
Annual income
$5,775.28
Full FCPT calculator →

Portfolio growth — MDCLF vs FCPT

📍 FCPT pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMDCLFFCPT
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MDCLF + FCPT cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MDCLF pays
FCPT pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MDCLF
Annual income on $10K today (after 15% tax)
$494.33/yr
After 10yr DRIP, annual income (after tax)
$716.32/yr
FCPT
Annual income on $10K today (after 15% tax)
$514.49/yr
After 10yr DRIP, annual income (after tax)
$4,908.99/yr
At 15% tax rate, FCPT beats the other by $4,192.67/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MDCLF + FCPT for your $10,000?

MDCLF: 50%FCPT: 50%
100% FCPT50/50100% MDCLF
Portfolio after 10yr
$39.2K
Annual income
$3,309.00/yr
Blended yield
8.44%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on FCPT right now

MDCLF
Analyst Ratings
1
Buy
Consensus: Buy
Altman Z
5.5
Piotroski
5/9
FCPT
Analyst Ratings
5
Buy
10
Hold
Consensus: Hold
Price Target
$27.00
+14.2% upside vs current
Range: $25.00 — $29.00
Altman Z
1.4
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MDCLF buys
0
FCPT buys
0
No recent congressional trades found for MDCLF or FCPT in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMDCLFFCPT
Forward yield5.82%6.05%
Annual dividend / share$2.00$1.43
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.8%
Portfolio after 10y$29.3K$49.1K
Annual income after 10y$842.73$5,775.28
Total dividends collected$7.2K$24.1K
Payment frequencyquarterlyquarterly
SectorStockREIT
Analyst consensusBuyHold

Year-by-year: MDCLF vs FCPT ($10,000, DRIP)

YearMDCLF PortfolioMDCLF Income/yrFCPT PortfolioFCPT Income/yrGap
1← crossover$11,282$581.56$11,401$700.92$119.00FCPT
2$12,684$613.17$13,064$864.84$380.00FCPT
3$14,217$644.32$15,051$1,072.48$834.00FCPT
4$15,887$674.91$17,442$1,337.22$1.6KFCPT
5$17,704$704.85$20,340$1,677.08$2.6KFCPT
6$19,677$734.08$23,880$2,116.57$4.2KFCPT
7$21,817$762.53$28,241$2,689.36$6.4KFCPT
8$24,134$790.14$33,660$3,442.07$9.5KFCPT
9$26,641$816.89$40,456$4,439.95$13.8KFCPT
10$29,348$842.73$49,063$5,775.28$19.7KFCPT

MDCLF vs FCPT: Complete Analysis 2026

MDCLFStock

MedinCell S.A. develops various therapeutic solutions. It develops solutions based on BEPO, a technology for long-acting injectable products based on proprietary copolymers and a biocompatible solvent, which solubilizes or suspends the active pharmaceutical ingredients. The company's products in development include mdc-IRM, a subcutaneous injection in Phase III trials for use in the treatment of schizophrenia; mdc-CWM, an intra-articular injection to treat pain and inflammation; and mdc-TJK, a subcutaneous injection in preclinical trials for use in the treatment of schizophrenia. Its product candidates in formulation research comprise subcutaneous injections, such as mdc-WWM for contraception; mdc-ANG for CNS related treatments; mdc-ELK for depression; and mdc-GRT for use in organ transplant, as well as perineural injections, including mdc-CMV for anesthesia and pain, and mdc-NVA for pain. The company is based in Jacou, France.

Full MDCLF Calculator →

FCPTREIT

FCPT, headquartered in Mill Valley, CA, is a real estate investment trust primarily engaged in the acquisition and leasing of restaurant properties. The Company seeks to grow its portfolio by acquiring additional real estate to lease, on a net basis, for use in the restaurant and retail industries.

Full FCPT Calculator →
📬

Get this MDCLF vs FCPT comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MDCLF vs SCHDMDCLF vs JEPIMDCLF vs OMDCLF vs KOMDCLF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.